Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05737745 · ClinicalTrials.gov registry record · NA
FitEx for Endometrial Cancer Survivors: Initial Efficacy
A NA study of Obesity and Endometrial Cancer, sponsored by Carilion Clinic.
- Completed
- Registry status
- NA
- Development phase
- 111
- Enrollment target
- 1
- Study location
NCT05737745: Completed NA study of Obesity and Endometrial Cancer, sponsored by Carilion Clinic.
NCT05737745 is a NA study of Obesity and Endometrial Cancer that has completed, run by Carilion Clinic. The registered enrollment target is 111 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05737745, a NA study of Obesity and Endometrial Cancer, has completed, sponsored by Carilion Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 111 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to compare physical activity outcomes between endometrial cancer survivors randomized to 1 of 3 conditions: 1) usual care, 2) FitEx, 3) FitEx+yoga. Survivors randomized to FitEx groups will recruit \~3 support team members to complete the intervention with them. The main question\[s\] it aims to answer are: * Do FitEx groups undertake more physical activity than the usual care group? * Are there differences in quality of life, self-compassion, flourishing, self-efficacy, social support, habit formation, and fruit /vegetable consumption Participants will: * Wear a Fitbit * Complete surveys * Participate in 30 minute weekly virtual meetings (FitEx groups only) * Receive weekly newsletters (FitEx groups only)
Primary Outcome
Among survivors, compare changes in objective moderate-vigorous physical activity (MVPA) obtained from FitBits (continuous tracking) between intervention groups and usual care (FitEx-ECS vs. control and FitEx-ECS+yoga vs. control)
Conditions Studied
Interventions
- BEHAVIORAL Self-monitoring
- BEHAVIORAL Group-dynamics
- BEHAVIORAL Weekly virtual sessions- Standard
- BEHAVIORAL Newsletters- Standard
- BEHAVIORAL Newsletters- Yoga
Study Locations (1)
Virginia
- Carilion Clinic - Roanoke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2023-02-01 |
| Est. Completion | 2024-06-20 |
| Phase | NA |
What the finished NCT05737745 record still lists
NCT05737745 is an interventional study that assigns participants to a tested intervention. The registered 111 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (86% lower).
The record links to 5 conditions, with Obesity appearing as the primary indexed condition, and to 5 interventions - of which Self-monitoring is the first listed.
NCT05737745 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT05737745 about?
NCT05737745 is a clinical study titled "FitEx for Endometrial Cancer Survivors: Initial Efficacy". The goal of this clinical trial is to compare physical activity outcomes between endometrial cancer survivors randomized to 1 of 3 conditions: 1) usual care, 2) FitEx, 3) FitEx+yoga. Survivors randomized to FitEx groups will recruit \~3 support team members to complete the intervention with them. Th...
What is the current status of trial NCT05737745?
This trial is currently completed. It is a NA study. The enrollment target is 111 participants. The study started on 2023-02-01. Estimated completion is 2024-06-20.
What conditions does trial NCT05737745 study?
This clinical trial studies the following conditions: Obesity, Endometrial Cancer, Quality of Life, Sedentary Behavior, Survivorship.
What interventions are being tested in trial NCT05737745?
The interventions under investigation include: Self-monitoring (BEHAVIORAL), Group-dynamics (BEHAVIORAL), Weekly virtual sessions- Standard (BEHAVIORAL), Newsletters- Standard (BEHAVIORAL), Newsletters- Yoga (BEHAVIORAL).
Who is sponsoring clinical trial NCT05737745?
This trial is sponsored by Carilion Clinic, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05737745 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05737745's enrollment target sits among peer trials
111 457th of 1053 higher than 597 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03875716 · 111 participants · NA
Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
- NCT04693468 · 111 participants · Phase 1
Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
- NCT05263050 · 111 participants · Phase 2
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
- NCT05600842 · 111 participants
De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI